↓ Skip to main content

Dove Medical Press

Article Metrics

Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives

Overview of attention for article published in Therapeutics and Clinical Risk Management, January 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)

Mentioned by

twitter
5 tweeters

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
27 Mendeley
Title
Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives
Published in
Therapeutics and Clinical Risk Management, January 2019
DOI 10.2147/tcrm.s160248
Pubmed ID
Authors

Teng Moua, Jay H. Ryu

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Other 8 30%
Student > Ph. D. Student 4 15%
Professor > Associate Professor 3 11%
Student > Master 3 11%
Researcher 2 7%
Other 2 7%
Unknown 5 19%
Readers by discipline Count As %
Medicine and Dentistry 9 33%
Biochemistry, Genetics and Molecular Biology 2 7%
Nursing and Health Professions 2 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Engineering 2 7%
Other 3 11%
Unknown 7 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 February 2019.
All research outputs
#7,732,213
of 14,331,597 outputs
Outputs from Therapeutics and Clinical Risk Management
#431
of 1,010 outputs
Outputs of similar age
#147,579
of 325,441 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 2 outputs
Altmetric has tracked 14,331,597 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,010 research outputs from this source. They receive a mean Attention Score of 4.6. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,441 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them